Bio Nordix ApS: Financial statements 2023
CVR: 35053948
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Bio Nordix ApS (CVR 35053948) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 638,435 and a net result of DKK 18,147 compared with DKK 20,645 the year before. That is a decrease of 11.2% compared with the year before. Equity in the 2023 report amounted to DKK 378,331. The solvency ratio was 85.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 638,435
- Profit/Loss
- DKK 18,147
- Equity
- DKK 378,331
- Total Assets
- DKK 442,200
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 638K | 18K | 378K | 1 |
| 2022 | - | 719K | 21K | 360K | 1 |
| 2021 | - | 684K | -18K | 340K | 1 |
| 2020 | - | 587K | -2K | 357K | 1 |
| 2019 | - | 767K | 131K | 488K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Bio Nordix ApS
Bio Nordix ApS was a Danish company of the type Anpartsselskab based in Hornbæk, founded in 2013. The company has been dissolved on 16 July 2026. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named ØRESUND ADVENTURES ApS and MOSV BIOPLASMA ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -6,770 and a net result of DKK -451,969 compared with DKK 67,543 the year before. Equity in the 2025 report amounted to DKK -6,095.